IMAC Holdings Inc. (BACK) is a Medical Specialities company listed on NASDAQ. There were no new wire items for BACK in the last 30 days. The most recent was published Mar 31, 2026.
Latest news
25 items- SECSEC Form 15-12G filed by IMAC Holdings Inc.15-12G - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECSEC Form 10-Q filed by IMAC Holdings Inc.10-Q - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECSEC Form NT 10-Q filed by IMAC Holdings Inc.NT 10-Q - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Leadership Update, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- PRIgnite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage CancersThe First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (OTCQB:BACK), today announced that it has entered into a research collaboration with Inova Health to apply Ignite's Reverse Phase Protein Array (RPPA) technology to tumor samples from patients, primarily with late-stage gastrointestinal cancers. The data provided from the analysis by RPPA will be used to help oncologists select from multiple treatment options where no current guidance is available. Under the agreement, Ignite will analyze up
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- PRIMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker DiscoveryProject will leverage Ignite Proteomics' reverse-phase protein array (RPPA) platform to profile tumor-immune signaling in breast-cancer samples Golden, CO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (OTCQB:BACK), today announced a one-year research collaboration with Vanderbilt University Medical Center (VUMC) to characterize protein-signaling pathways that help breast-tumor cells evade the immune system. Under the agreement, VUMC will provide de-identified formalin-fixed, paraffin-embedded (FFPE) tumor tissue from patients undergoing standard of care chemotherapy and immunotherapy, while Ignite will perform laser-capture micro-dissection
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
- SECSEC Form 25-NSE filed by IMAC Holdings Inc.25-NSE - IMAC Holdings, Inc. (0001729944) (Subject)
- SECIMAC Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - IMAC Holdings, Inc. (0001729944) (Filer)
BACK FAQ
6 questionsWhat is the latest news on BACK?
Quantisnow has not tracked any new filings, ratings or press releases for BACK in the last 30 days. The most recent wire item was published on March 31, 2026.Where does BACK stock trade?
IMAC Holdings Inc. (BACK) is listed on NASDAQ.What sector and industry is BACK in?
IMAC Holdings Inc. operates in the Health Care sector, Medical Specialities industry.When did IMAC Holdings Inc. go public?
IMAC Holdings Inc. (BACK) completed its IPO in 2019.What companies are similar to BACK?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.), NTRA (Natera Inc.). Compare BACK side-by-side with any of them on Quantisnow.How can I track BACK on Quantisnow?
Quantisnow aggregates IMAC Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BACK to receive live email and push alerts on every new disclosure.